Marketing-authorisation holder · United Kingdom
Aurobindo Pharma Limited
125 medicines in 4 countries, as authorisation holder and manufacturer.
Loading your page…
Loading your page…
Marketing-authorisation holder · United Kingdom
125 medicines in 4 countries, as authorisation holder and manufacturer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 125
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ABACAVIR SULFATE AND LAMIVUDINE600mg base; 300mg · Tablet | Abacavir, Lamivudine | United States | Marketed | 2016 |
| AFIRMELLE0.02mg; 0.1mg · Tablet | Ethinyl estradiol, Levonorgestrel | United States | Marketed | 2016 |
| AMOXICILLIN200mg | 400mg · Tablet, for suspension | Amoxicillin | United States | Not marketed | 2007 |
| AMPICILLIN TRIHYDRATE250mg base | 500mg base · Capsule | Ampicillin | United States | Marketed | 1971 |
| ATAZANAVIR SULFATE100mg | 100mg base | 150mg | 150mg base | 200mg | 200mg base | 300mg | 300mg base · Capsule | Atazanavir | United States | Marketed | 2008 |
| ATHENTIA NEXT1.5mg · Tablet | Levonorgestrel | United States | Marketed | 2015 |
| AUROVELA 1/200.02mg; 1mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Marketed | 2017 |
| AUROVELA 1.5/300.03mg; 1.5mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Marketed | 2017 |
| AUROVELA 24 FE0.02mg; 1mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Marketed | 2017 |
| AUROVELA FE 1/200.02mg; 1mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Marketed | 2017 |
| AUROVELA FE 1.5/300.03mg; 1.5mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Marketed | 2017 |
| AYUNA0.03mg; 0.15mg · Tablet | Ethinyl estradiol, Levonorgestrel | United States | Marketed | 2016 |
| AZELASTINE HYDROCHLORIDE ALLERGY0.2055mg/spray · Spray, metered | Azelastine | United States | Marketed | 2024 |
| BARICITINIB1mg | 2mg · Tablet | Baricitinib | United States | Not marketed | 2024 |
| BETAMETHASONE DIPROPIONATE0.05% base · Cream | Betamethasone | United States | Marketed | 1984 |
| BROMOCRIPTINE MESYLATE2.5mg base · Tablet | Bromocriptine | United States | Marketed | 1998 |
| BUPROPION HYDROCHLORIDE100mg | 150mg | 200mg | 300mg · Tablet, extended release | Bupropion | United States | Marketed | 2003 |
| BUSPIRONE HYDROCHLORIDE10MG | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 12.5MG | 15MG | 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 2.5MG | 30MG | 5MG | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiv · Tablet | Buspirone | United States | Marketed | 2001 |
| CEFADROXIL125mg base/5ml | 250mg base/5ml | 500mg base/5ml · For suspension | Cefadroxil | United States | Marketed | 1989 |
| CEFIXIME100mg/5ml | 200mg/5ml | 500mg/5ml · For suspension | Cefixime | United States | Marketed | 2015 |
| CEFOTAXIME SODIUM FOR INJECTION BP2 g / vial · Powder For Solution | Cefotaxime | Canada | Authorised | |
| CEFOTAXIME SODIUM FOR INJECTION BP0.5 g / vial · Powder For Solution | Cefotaxime | Canada | Authorised | |
| CEFOTAXIME SODIUM FOR INJECTION BP1 g / vial · Powder For Solution | Cefotaxime | Canada | Authorised | |
| CEFPROZIL250mg | 500mg · Tablet | Cefprozil | United States | Marketed | 2005 |
| CETIRIZINE HYDROCHLORIDE5mg/5ml · Solution | Cetirizine | United States | Marketed | 2006 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 106 | 93 | 13 | CompaniesAll medicines |
| Romania | 10 | 0 | 10 | CompaniesAll medicines |
| Canada | 5 | 5 | 0 | CompaniesAll medicines |
| Saudi Arabia | 4 | 4 | 0 | CompaniesAll medicines |
Also in the registers of Brazil
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.